| Basic Materials | 9.50% | |
|---|---|---|
| Consumer Cyclical | 8.89% | |
| Financial Services | 18.89% | |
| Real Estate | 1.03% | |
| Consumer Defensive | 15.46% | |
| Healthcare | 12.59% |
| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 52.33 | -0.49 (-0.93%) | 38.47 - 53.32 | 2.0 million (Above Avg) |
Market data as of 4:00PM 05/22/13. Quotes are delayed by at least 15 min.
The investment seeks to track the performance of a benchmark index that measures the investment return of stocks issued by companies located in the major markets of Europe. The fund employs an indexing investment approach by investing all, or substantially all, of its assets in the common stocks included in the FTSE Developed Europe Index. The FTSE Developed Europe Index is made up of approximately 511 common stocks of companies located in 17 European countries-mostly companies in the United Kingdom, France, Switzerland, and Germany.
| Open | 52.81 |
|---|---|
| Previous Close | 52.82 |
| Day's Range | 52.15 - 53.32 |
| Avg Volume (10 Day) | 1.6M |
| Total Assets | $10.33B |
| Expense Ratio | 0.12% |
| Yield (Trailing 12 Mo.) | 3.33% |
| Fund Inception | 03/04/2005 |
| Timeframe | VGK | S&P 500 | Europe Stock |
|---|---|---|---|
| 1 Month | 4.29% | 1.93% | 4.48% |
| 3 Month | 1.35% | 7.18% | 1.04% |
| Year-to-Date | 6.46% | 12.74% | 6.29% |
| 1 Year | 18.32% | 16.89% | 18.15% |
| 3 Year | 7.72% | 12.80% | 5.63% |
| 5 Year | -1.74% | 5.21% | -3.88% |
| 10 Year | -- | 7.88% | 7.30% |
| Since Inception | 4.17% | 10.38% | -- |
| Basic Materials | 9.50% | |
|---|---|---|
| Consumer Cyclical | 8.89% | |
| Financial Services | 18.89% | |
| Real Estate | 1.03% | |
| Consumer Defensive | 15.46% | |
| Healthcare | 12.59% |
| Utilities | 3.88% | |
|---|---|---|
| Communication Services | 5.69% | |
| Energy | 9.64% | |
| Industrials | 10.26% | |
| Technology | 4.17% |
| Company | YTD Return | % of Assets |
|---|---|---|
| Nestle SA | 9.65% | 3.16% |
| HSBC Holdings PLC | 4.07% | 2.66% |
| Novartis AG | 17.50% | 2.25% |
| Roche Holding AG | 23.65% | 2.22% |
| Vodafone Group PLC | 21.77% | 1.90% |
| BP PLC | 4.81% | 1.81% |
| Royal Dutch Shell PLC Class A | -0.16% | 1.66% |
| GlaxoSmithKline PLC | 20.09% | 1.56% |
| Sanofi | -- | 1.56% |
| British American Tobacco PLC | -- | 1.41% |
| Valuation | VGK | Category Range |
|---|---|---|
| Price/Earnings | 12.14 | |
| Price/Book | 1.53 | |
| Price/Sales | 0.91 | |
| Price/Cash Flow | 7.98 | |
| Dividend Yield | 3.2 | |
| LT Earnings | 8.48 | |
| Historical Earnings | 9.61 | |
| Sales Growth | -16.81 | |
| Cash-Flow Growth | -27.83 | |
| Book-Value Growth | -0.88 |
| Management Style | |||
|---|---|---|---|
| Large Cap | |||
| Medium Cap | |||
| Small Cap | |||
![]() | ![]() | ![]() |

| Rating | vs Category | |
|---|---|---|
| Overall | ![]() ![]() ![]() | |
| Risk | Avg | |
| Return | Avg |
| Beta | 1.14 |
|---|---|
| Standard Deviation | 22.62 |
| Alpha | -0.40 |
| Sharpe Ratio | 0.44 |
| Mean | 10.43 |
| R-Squared | 97.05 |
| Pretax Return | 7.72% |
|---|---|
| Tax-adjusted Return | 6.81% |
| Tax Cost Ratio | 0.84% |
| Potential Cap Gains | -34.60% |